Literature DB >> 22563771

GPCRs promote the release of zinc ions mediated by nNOS/NO and the redox transducer RGSZ2 protein.

Pilar Sánchez-Blázquez1, María Rodríguez-Muñoz, Concha Bailón, Javier Garzón.   

Abstract

AIMS: Morphine signaling via the μ-opioid receptor (MOR) is coupled to redox-dependent zinc release from endogenous stores. Thus, MOR activation stimulates the complex formed by RGSZ2 (a regulator of G protein signaling) and neural nitric oxide synthase (nNOS) to produce NO, and to recruit PKCγ and Raf-1 in a zinc-dependent manner. Accordingly, we investigated whether redox regulation of zinc metabolism was unique to the MOR, or if it is a signaling mechanism shared by G-protein coupled receptors (GPCRs).
RESULTS: A physical interaction with the RGSZ2-nNOS complex was detected for the following GPCRs: neuropeptides, MOR and δ-opioid (DOR); biogenic amines, 5HT1A, 5HT2A, α2A, D1 and D2; acetylcholine, muscarinic M2 and M4; excitatory amino acid glutamate, mGlu2 and mGlu5; and derivatives of arachidonic acid (anandamide), CB1. Agonist activation of these receptors induced the release of zinc ions from the RGSZ2 zinc finger via a nNOS/NO-dependent mechanism, recruiting PKCγ and Raf-1 to the C terminus or the third internal loop of the GPCR. INNOVATION: A series of GPCRs share an unexpected mechanistic feature, the nNOS/NO-dependent regulation of zinc ion signaling via a redox mechanism. The RGSZ2 protein emerges as a potential redox zinc switch that converts NO signals into zinc signals, thereby able to modulate the function of redox sensor proteins like PKCγ or Raf-1.
CONCLUSION: Redox mechanisms are crucial for the successful propagation of GPCR signals in neurons. Thus, dysfunctions of GPCR-regulated NO/zinc signaling may contribute to neurodegenerative and mood disorders such as Alzheimer's disease and depression.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22563771     DOI: 10.1089/ars.2012.4517

Source DB:  PubMed          Journal:  Antioxid Redox Signal        ISSN: 1523-0864            Impact factor:   8.401


  19 in total

Review 1.  Regulator of G Protein Signaling 17 as a Negative Modulator of GPCR Signaling in Multiple Human Cancers.

Authors:  Michael P Hayes; David L Roman
Journal:  AAPS J       Date:  2016-02-29       Impact factor: 4.009

Review 2.  Zinc and the modulation of redox homeostasis.

Authors:  Patricia I Oteiza
Journal:  Free Radic Biol Med       Date:  2012-08-25       Impact factor: 7.376

3.  Cannabinoid receptors couple to NMDA receptors to reduce the production of NO and the mobilization of zinc induced by glutamate.

Authors:  Pilar Sánchez-Blázquez; María Rodríguez-Muñoz; Ana Vicente-Sánchez; Javier Garzón
Journal:  Antioxid Redox Signal       Date:  2013-06-01       Impact factor: 8.401

4.  TNF signals via neuronal-type nitric oxide synthase and reactive oxygen species to depress specific force of skeletal muscle.

Authors:  Shawn A Stasko; Brian J Hardin; Jeffrey D Smith; Jennifer S Moylan; Michael B Reid
Journal:  J Appl Physiol (1985)       Date:  2013-04-04

5.  RGS17: an emerging therapeutic target for lung and prostate cancers.

Authors:  Christopher R Bodle; Duncan I Mackie; David L Roman
Journal:  Future Med Chem       Date:  2013-06       Impact factor: 3.808

Review 6.  Nitric oxide and zinc-mediated protein assemblies involved in mu opioid receptor signaling.

Authors:  María Rodríguez-Muñoz; Javier Garzón
Journal:  Mol Neurobiol       Date:  2013-05-11       Impact factor: 5.590

Review 7.  Reactive Oxygen-Related Diseases: Therapeutic Targets and Emerging Clinical Indications.

Authors:  Ana I Casas; V Thao-Vi Dao; Andreas Daiber; Ghassan J Maghzal; Fabio Di Lisa; Nina Kaludercic; Sonia Leach; Antonio Cuadrado; Vincent Jaquet; Tamara Seredenina; Karl H Krause; Manuela G López; Roland Stocker; Pietro Ghezzi; Harald H H W Schmidt
Journal:  Antioxid Redox Signal       Date:  2015-11-10       Impact factor: 8.401

8.  The σ1 receptor engages the redox-regulated HINT1 protein to bring opioid analgesia under NMDA receptor negative control.

Authors:  María Rodríguez-Muñoz; Pilar Sánchez-Blázquez; Raquel Herrero-Labrador; Ricardo Martínez-Murillo; Manuel Merlos; José Miguel Vela; Javier Garzón
Journal:  Antioxid Redox Signal       Date:  2015-02-18       Impact factor: 8.401

9.  HINT1 protein cooperates with cannabinoid 1 receptor to negatively regulate glutamate NMDA receptor activity.

Authors:  Ana Vicente-Sánchez; Pilar Sánchez-Blázquez; María Rodríguez-Muñoz; Javier Garzón
Journal:  Mol Brain       Date:  2013-10-05       Impact factor: 4.041

Review 10.  The cannabinoid receptor 1 associates with NMDA receptors to produce glutamatergic hypofunction: implications in psychosis and schizophrenia.

Authors:  Pilar Sánchez-Blázquez; María Rodríguez-Muñoz; Javier Garzón
Journal:  Front Pharmacol       Date:  2014-01-02       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.